© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
Sacral neuromodulation shows efficacy in OAB patients with Parkinson’s disease
“Of those patients that did the test phase 82% of them actually went on to full implants,” says Sarah Martin, DO.
In this video, Sarah Martin, DO, discusses the background and key findings from the recent Neurourology & Urodynamics study, “Is sacral neuromodulation effective in patients with Parkinson's disease? A retrospective review,” for which she served as first author. Martin is an FPMRS fellow at Glickman Urological & Kidney Institute at Cleveland Clinic.
